Searched for
DRUG REPOSITIONING
Stocks in news: Sun Pharma, Tech Mahindra, Tata Motors, Voltas, ONGCIndian markets saw a dip on Friday, with IT stocks leading the decline. Analysts suggest profit-taking occurred near the 24,150 mark. Despi...- Why is the US stock market crashing today? S&P 500 erases all gains and wipes out $1.3 trillion in 2 hours as Nasdaq and Dow turn sharply lower - Tech stocks and chip sector collapseThe US stock market crash today caught many investors off guard. Early gains quickly vanished as the S&P 500 erased more than $1.3 trillion...
- Comm secy asks pharma sector to cut dependence on imported raw materialsIndia's Commerce Secretary Rajesh Agrawal has called for greater self-reliance in the pharmaceutical sector. He wants the industry to produ...
- Work on reducing import dependence for raw materials: Commerce Secretary Rajesh Agrawal to pharma industryCommerce Secretary Rajesh Agrawal has called on India's pharmaceutical sector to boost domestic production and reduce reliance on imported ...
- India weight-loss market reset? In setback for Novo Nordisk, Dr Reddy's Lab allowed to make semaglutideThe order follows the court’s view that Novo Nordisk’s patent appears prima facie invalid -- a finding that could reshape competitive dynam...
- Repurposed anti-cholesterol drug statin can stymie cancer, help support treatment, say researchersStatins, drugs for high cholesterol, show promise in slowing colorectal cancer growth. Researchers at Shiv Nadar University and IISER Pune ...
- Ashish Kacholia picks up 17% stake in largest homegrown burger chain JumbokingAce investor Ashish Kacholia has picked up a 17.2% stake in homegrown burger chain Jumboking for an undisclosed amount, becoming its second...
- DSP Small cap mutual fund review: Needs to find footing quicklyThe fund’s performance in recent years has been middling, managing to beat its index yet lagging many of its peers. The fund must find its ...
- 1998 nuclear tests demonstrated India's scientific capability, political will: Ram Nath KovindAfter the 1998 tests, the US and its allies had again imposed sanctions against India but a decade later, the Indo-US civil nuclear coopera...
- Precision medicine: Zuckerberg backs Indian-origin scientist with formula to jolt drug marketDr Butte's aim is drug re-positioning. It is not about getting a new drug out in the market, but finding a new use for an old drug that's a...
- Breakthrough in chikungunya may come from IIT-RoorkeeRoorkee, Oct 5 (IANS) In a move that could lead to a breakthrough in combating chikungunya, the Indian Institute of Technology (IIT)-Roorke...
- Phase I/II trials for DFU potential drug successful: NovaLeadPune-based NovaLead Pharma today announced completion of global phase I/II clinical trial of its repositioned investigational drug, Galnoba...
- USFDA issues warning to Indian drug maker Marck BiosciencesMarck Biosciences, now known as Amanta Healthcare received warning letter by US drug authority. USFDA found flase data and dead & decaying ...
- Nine new drugs under clinical stage: Dr Reddy'sAccording to a filing with US SEC, the drug maker said as of March 31, 2014, it had 20 active products in the proprietary products pipeline.
- Six new drugs in clinical development stage: Dr Reddy'sThe drug maker said as of March 31, 2013, DRL had 21 active products in the proprietary products pipeline, of which six are in clinical dev...
- GVK Bio, USFDA in drug repositioning collaborationThe company is looking forward to continue working with the FDA with a view to further enhancing the utility of the product, the company sa...
- Cancer medicines for as low as Rs 1,000 a month on wayTata Memorial Hospital’s doctors are working on alternatives that could cost less than Rs 1,000 a month.
- Pharma companies fear generics will erode their marginsIndian and foreign drug makers have already suffered heavy revenue loss due to changes in drug pricing or procurement policies in countries...
- Dr Reddy's Laboratories' revenues in Q1 grew by 18% to 1,970 crPharma major Dr Reddy's Laboratories' revenues in the first quarter grew by 18% to 1,970 crore compared to the corresponding period.
- Nicholas Piramal buys out Boots CoThe acquisition follows Reckitt Benckiser's global acquisition of Alliance Boots' OTC business.
Load More
